Jishan Sun
Overview
Explore the profile of Jishan Sun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
783
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu W, Zheng S, Na R, Wei L, Sun J, Gallagher J, et al.
Mol Cancer Res
. 2020 Oct;
18(12):1815-1824.
PMID: 33115829
We aim to understand, from acquired genetic alterations in tumors, why African American (AA) men are more likely to develop aggressive prostate cancer. By analyzing somatic mutations in 39 genes...
2.
Liu W, Hou J, Petkewicz J, Na R, Wang C, Sun J, et al.
Prostate
. 2020 Aug;
80(14):1253-1262.
PMID: 32803894
Background: To assess the feasibility of a novel DNA-based probe panel to detect copy number alterations (CNAs) in prostate tumor DNA and its performance for predicting clinical progression. Methods: A...
3.
Zhang N, Chen S, Wu L, Wu Y, Jiang G, Shao J, et al.
J Cancer
. 2019 Nov;
10(26):6761-6766.
PMID: 31777606
Here we conducted an evidence-based study in developing and validating a urinary biomarker combination of gene methylation assays in patients with hematuria. A number of 99 urine samples were obtained...
4.
Wu Y, Jiang G, Zhang N, Liu S, Lin X, Perschon C, et al.
Eur Urol Focus
. 2018 Oct;
6(2):284-291.
PMID: 30309818
Background: DNA methylation biomarkers for bladder cancer (BCa) have not been evaluated extensively in the Chinese population. Objective: To develop and validate a urinary biomarker combination of methylation assays in...
5.
Liu X, Xu Y, Sun J, Zhang Z, Wang J, Ding C, et al.
Prenat Diagn
. 2017 Mar;
37(5):460-468.
PMID: 28258706
Objective: The objective of this study is to demonstrate the accuracy and feasibility of using single nucleotide polymorphism (SNP) array-based preimplantation genetic haplotyping (PGH) in Chinese population, as the currently...
6.
Liu W, Xie C, Thomas C, Kim S, Lindberg J, Egevad L, et al.
Cancer
. 2013 Apr;
119(13):2405-12.
PMID: 23609948
Background: This study sought to identify novel effectors and markers of localized but potentially life-threatening prostate cancer (PCa), by evaluating chromosomal copy number alterations (CNAs) in tumors from patients who...
7.
Wertz N, Vazquez J, Wells K, Sun J, Butler J
Mol Immunol
. 2013 Apr;
55(3-4):319-28.
PMID: 23570908
We characterized 239 lambda rearrangements from fetal and germfree (GF) piglets to: (1) determine if transcripts recovered from the earliest sites of B cell lymphogenesis were unique (2) determine what...
8.
Xu J, Mo Z, Ye D, Wang M, Liu F, Jin G, et al.
Nat Genet
. 2012 Oct;
44(11):1231-5.
PMID: 23023329
Prostate cancer risk-associated variants have been reported in populations of European descent, African-Americans and Japanese using genome-wide association studies (GWAS). To systematically investigate prostate cancer risk-associated variants in Chinese men,...
9.
Cheng Y, Liu W, Kim S, Sun J, Lu L, Sun J, et al.
Cancer Genet
. 2011 Aug;
204(7):375-81.
PMID: 21872824
PPP2R2A, mapped to 8p21.2, codes for the α isoform of the regulatory B55 subfamily of protein phosphatase 2 (PP2A). PP2A is one of the four major serine/threonine phosphatases and is...
10.
Lu Y, Sun J, Kader A, Kim S, Kim J, Liu W, et al.
Prostate
. 2011 Jun;
72(4):376-85.
PMID: 21671247
Background: Genome-wide association studies (GWAS) have identified approximately three dozen single nucleotide polymorphisms (SNPs) consistently associated with prostate cancer (PCa) risk. Despite the reproducibility of these associations, the molecular mechanism...